ReviewPublished 12 October 2026Functional single-cell omics in gynecological cancers immunotherapy: from heterogeneity dissection to clinical translationDong-mei Li · Kai-ge Pei · Bo-wen Yang · Ming-rong Qie · Jin-feng Xu · Lan Zhong · Liang SongFrontiers in Immunologydoi 10.3389/fimmu.2026.1981010
ReviewPublished 12 October 2026Nutritional regulation of the tumor immune microenvironment: metabolic mechanisms, immunotherapy response, and nursing implicationsDanwei Zhong · Congjue Li · Zunyao XiaoFrontiers in Immunologydoi 10.3389/fimmu.2026.1938564
ReviewPublished 12 October 2026Precision immuno-oncology in triple-negative breast cancer: from PD-L1 to multimodal biomarkers, ADC–ICI combinations, and global real-world integrationJingna WuFrontiers in Immunologydoi 10.3389/fimmu.2026.1911879
Original ResearchPublished 12 October 2026SCD1 inhibition promotes lipid peroxidation and enhances anti-PD-1 response in triple-negative breast cancerQuentin Herrera Garfia · Aurélien Azam · Eric Bonneil · Laetitia Montero-Ruiz · Mohsen Momeni · Mohammad Farran · Robin Jehay · Nor Eddine SounniFrontiers in Immunologydoi 10.3389/fimmu.2026.1843935
Mini ReviewPublished 9 October 2026Biomarker-guided immunotherapy in osteosarcoma: from immune microenvironment profiling to patient stratification and combination strategiesQingqing LiFrontiers in Medicinedoi 10.3389/fmed.2026.1987146
Mini ReviewPublished 7 October 2026Pan-cancer biomarkers of immune therapy resistance: mechanisms and clinical translationChao Wang · Dong YangFrontiers in Cell and Developmental Biologydoi 10.3389/fcell.2026.1895670
